Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$105.97 n/a | n/a%
11/27/15 - 12:59 PM ET
Company Profile
Price and Volume
Recent Price 105.97
52 Week High 112.40
52 Week Low 49.65
Avg. Daily Vol. (Mil) 0.34
Beta (3 year) 0.58
Share Related Items
Mkt Cap (Mil) 2,111.53
Shares Out (Mil) 19.93
Float (Mil) 15.49
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.80
Current Ratio 11.00
LT Debt/ Equity 2.90
Total Debt / Equity 2.90
Valuation Ratios
Price Earnings 69.10
Price/Sales 29.74
Price/Book 30.58
Price/Cash Flow 51.70
Per Share Data
Earnings 1.53
Sales 3.56
Book Value 3.47
Cash Flow 2.05
Business Summary
Ligand Pharmaceuticals Inc is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
Industry : Drugs
Sector: Health Care
Employees: 19
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 3.84
Previous Month (Mil) 3.94
Short Interest Ratio (Days) 11.00
Management Effectiveness
Return on Equity 42.60
Return on Assets 9.70
Return on Investments 10.90
Gross Margin 87.10
EBIT Margin 41.00
Profit Margin 41.50

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter